Refeyn launches new US HQ

Co-founder Philipp Kukura, who led the research team that invented the light-based bioanalytical tool for rapid, single-particle analysis, said: 

“It is amazing to witness the opening of Refeyn’s state-of-the-art US HQ today, having started in an early 19th century building above a burger joint in central Oxford, which feels like only yesterday.”

Spun out of Oxford University just six years ago, the firm’sinstruments are now used globally for applications in scientific discovery, R&D and therapeutics production. 

Refeyn’s laboratory space in the new HQ now enables customers across North America to visit to run samples and test applications. The firm ainms to achieve sustainability certification for this laboratory space, which includes a BSL-2 lab, service and R&D centres and applications lab. The new site also facilitates instrument maintenance, customer training sessions, and workshops support for Refeyn’s customers across North America and beyond.

CEO Gerry Mackay commented: “With the opening of our new US HQ, the success of Refeyn and mass photometry is evident as we now have over 180 employees globally and are currently recruiting more to support our expanding US customer-base from our new facility. 

“Furthermore, with over 300 scientific papers to date citing mass photometry, this literature highlights the ever-growing capabilities of this unique technology as it is increasingly adopted in life science laboratories around the world.”

The US HQ opening followed the successful third annual Mass Photometry Summit, where presenters included Dr. Di Wu of the National Institutes of Health, an early adopter of mass photometry, who talked about SEC-MP, a technique for AAV characterisation for gene therapy that he and colleagues published in 2023. Keynote speaker was professor Priyamvada Acharya from Duke University School of Medicine.